Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Common Stock | Options Exercise | $0 | +4.4K | +0.44% | $0.00 | 1.01M | Dec 27, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | +4.4K | $0.00* | 0 | Dec 27, 2022 | Common Stock | 4.4K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | This reflects the number of restricted stock units that vested on December 27, 2022. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |
F3 | All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. |